FIELD: medicine.
SUBSTANCE: invention refers to medicine, and aims at treating chronic gastritis with chronic erosions. If observing endothelial proliferation and angiomatosis of mucosal stroma vessels within chronic erosion, the latter is endoscopically coagulated by monopolar diathermocoagulation or silver nitrate chemical coagulation. It is followed by prescribing bismuth salts orally for impregnation of a coagulation crust.
EFFECT: method enables higher clinical effectiveness.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TISSUE THERAPY OF CHRONIC GASTRIC DISEASES | 2003 |
|
RU2234328C1 |
METHOD OF HEALING CHRONIC GASTRITIS AND DUODENUM ULCER DISEASE | 2000 |
|
RU2187318C2 |
METHOD OF TREATING EROSIONS AND ULCERS OF GASTRIC MUCOSA | 2011 |
|
RU2449787C1 |
METHOD FOR TREATING HELICOBACTER-ASSOCIATED CHRONIC DUODENAL ULCER | 2003 |
|
RU2252777C2 |
METHOD FOR TREATING CHRONIC GASTRITIS ASSOCIATED WITH HELICOBACTER INFECTION | 2007 |
|
RU2373972C2 |
METHOD OF TREATING Helicobacter pylori ASSOCIATED CHRONIC EROSIVE GASTRITIS | 2009 |
|
RU2403925C1 |
METHOD OF TREATING PYLORIC HELICOBACTERIOSIS | 2012 |
|
RU2506076C1 |
METHOD FOR PREDICTING THE STATE OF ANTRAL DEPARTMENT OF GASTRIC MUCOSA IN CHILDREN AND TEENAGERS | 2006 |
|
RU2321857C1 |
METHOD OF TREATING Helicobacter pylori ASSOCIATED CHRONIC ULCEROUS DISEASE OF STOMACH AND DUODENUM | 2010 |
|
RU2416408C1 |
METHOD OF ASSESSMENT OF THE SEVERITY OF THE COURSE OF CHRONIC EROSIVE GASTRITIS ASSOCIATED WITH HELICOBACTER PYLORI AND EPSTEIN-BARR VIRUS | 2017 |
|
RU2659134C1 |
Authors
Dates
2012-06-10—Published
2010-11-30—Filed